Conmed Stock Analysis

CONMED Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.99. Some equities with similar Price to Book (P/B) outperform the market in the long run. CONMED has Price/Earnings (P/E) ratio of 188.03. The entity last dividend was issued on the 20th of December 2024. The firm had 3:2 split on the 10th of September 2001. CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida. C O operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 3800 people. For more info on CONMED please contact Curt Hartman at 727 392 6464 or go to https://www.conmed.com.

CONMED Investment Alerts

CONMED Upcoming and Recent Events

CONMED Largest EPS Surprises

View All Earnings Estimates

CONMED Environmental, Social, and Governance (ESG) Scores

CONMED Stock Institutional Investors

Note, although CONMED's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

CONMED Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.94 B.

CONMED Profitablity

The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.

Management Efficiency

CONMED has return on total asset (ROA) of 0.0432 % which means that it generated a profit of $0.0432 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1474 %, meaning that it created $0.1474 on every $100 dollars invested by stockholders. CONMED's management efficiency ratios could be used to measure how well CONMED manages its routine affairs as well as how well it operates its assets and liabilities. As of February 26, 2025, Return On Tangible Assets is expected to decline to 0.08. In addition to that, Return On Capital Employed is expected to decline to 0.09. At present, CONMED's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 122.2 M, whereas Net Tangible Assets are projected to grow to (642.7 M).

Technical Drivers

As of the 26th of February, CONMED shows the risk adjusted performance of (0.04), and Mean Deviation of 1.66. CONMED technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CONMED variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if CONMED is priced favorably, providing market reflects its regular price of 62.74 per share. Given that CONMED has information ratio of (0.07), we suggest you to validate CONMED's prevailing market performance to make sure the company can sustain itself in the future.

CONMED Price Movement Analysis

CONMED Insider Trading Activities

CONMED Outstanding Bonds

CONMED Predictive Daily Indicators

CONMED Corporate Filings

CONMED Forecast Models

CONMED's time-series forecasting models are one of many CONMED's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CONMED's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how CONMED prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CONMED shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CONMED. By using and applying CONMED Stock analysis, traders can create a robust methodology for identifying CONMED entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CONMED analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CONMED analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

CONMED stock analysis indicators help investors evaluate how CONMED stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CONMED shares will generate the highest return on investment. By understating and applying CONMED stock analysis, traders can identify CONMED position entry and exit signals to maximize returns.

When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.